Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion

NCT01581411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Central Retinal Vein Occlusion

Interventions

DRUG: Tissue Plasminogen Activator

Sponsor

Weill Medical College of Cornell University